KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Debt Ratio: 2010-2024

Historic Debt Ratio for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to 0.48.

  • Emergent BioSolutions' Debt Ratio rose 1.35% to 0.45 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.45, marking a year-over-year increase of 1.35%. This contributed to the annual value of 0.48 for FY2024, which is 95.01% up from last year.
  • Latest data reveals that Emergent BioSolutions reported Debt Ratio of 0.48 as of FY2024, which was up 95.01% from 0.24 recorded in FY2023.
  • Emergent BioSolutions' Debt Ratio's 5-year high stood at 0.48 during FY2024, with a 5-year trough of 0.14 in FY2022.
  • In the last 3 years, Emergent BioSolutions' Debt Ratio had a median value of 0.24 in 2023 and averaged 0.29.
  • In the last 5 years, Emergent BioSolutions' Debt Ratio crashed by 48.24% in 2022 and then surged by 95.01% in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Debt Ratio stood at 0.29 in 2020, then declined by 6.18% to 0.27 in 2021, then plummeted by 48.24% to 0.14 in 2022, then soared by 72.89% to 0.24 in 2023, then skyrocketed by 95.01% to 0.48 in 2024.